NFG
CSCI

Next Financial Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Next Financial Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
1
– – ﹤0.01% 3001
2021
Q3 		$0 Sell
1
-1
-50% -$71 ﹤0.01% 2826
2021
Q2 		$0 Buy
+2
New +$190 ﹤0.01% 2732
2014
Q4 		– Sell
-1
Closed -$8K – 2394
2014
Q3 		$8K Hold
1
– – ﹤0.01% 1887
2014
Q2 		$7K Buy
+1
New +$11.2K ﹤0.01% 858

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Next Financial Group's CSCI Position: Q4 2021 in Review

Next Financial Group held its COSCIENS Biopharma Inc. Common Stock (CSCI) position steady in Q4 2021 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3001.

Next Financial Group first reported a position in CSCI in Q2 2014 and has held it in 5 quarters since. The position peaked at $8K in Q3 2014. 29 funds tracked by Wall St. Rank hold CSCI as of Q4 2021.

  • Next Financial Group held 1 share of COSCIENS Biopharma Inc. Common Stock worth $0 as of Q4 2021.
  • Next Financial Group left its COSCIENS Biopharma Inc. Common Stock share count unchanged in Q4 2021.
  • COSCIENS Biopharma Inc. Common Stock made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #3001 holding.
  • Next Financial Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2014 and has held it in 5 quarters since.
  • Next Financial Group's COSCIENS Biopharma Inc. Common Stock position peaked at $8K in Q3 2014.
  • 29 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.